medigraphic.com

2014, Number 3

<< Back

Rev Cuba Endoc 2014; 25 (3)

Hypertension of adrenal origin and pregnancy

Torres HOF

Language: Spanish
References: 42
Page: 259-270
PDF size: 81.55 Kb.


ABSTRACT

Blood hypertension of adrenal origin associated to pregnancy is unfrequent and generates high maternal and fetal morbidity and mortality. Changes in the endocrine physiology during this phase modify the clinical and biochemical picture of hypertension-causing adrenal diseases. The objective of this review was to provide health professionals in charge of pregnancy care with updated information on endogenous hypercortisolism, primary aldosteronism and pheochromocytoma in pregnancy. This will allow them to diagnose and treat this disorder early and adequately by means of the clinical method. Relevant literature was reviewed and the latest medical advances in this field were presented.


REFERENCES

  1. Monticone S, Auchus RJ, Rainey WE. Adrenal disorders in pregnancy. Nat Rev Endocrinol. 2012;8:668-78.

  2. Ishimoto H, Jaffe RB. Development and function of human fetal adrenal corte: a key component in the feto-placental unit. Endoc Rev. 2011;32:317-55.

  3. Torres O, Felpeto M, Rodríguez A, Hernández A. Síndrome de Cushing y gestación. Presentación de una paciente. Rev Cubana Endocrinol. 1996;7(2):15-20.

  4. Borna S, Akbari S, Eftekhar T, Mostaan F. Cushing’s Syndrome During Pregnancy Secondary to Adrenal Adenoma. Acta Médica Iraní [serie en Internet]. 2012 [citado 12 agosto de 2013];50(1). Disponible en: http://journals.tums.ac.ir/. 4. Yanes M, Cruz J, Turcios S, Martínez O. Gestación y psicosis esteroidea en el curso del síndrome de Cushing. Rev Cubana Endocrinol. 2011;22(3):237-43.

  5. Goñi MJ. Cushing's syndrome: special issues. Endocrinol Nutr. 2009;56(5):251-61.

  6. Buescher MA, Mc Clamrock H, Adashi E. Cushing syndrome in pregnancy. Obstet Gynecol. 1992;79:130-7.

  7. Lindsay JR, Oldfield, EH Nieman LK. Cushing’s syndrome during pregnancy: special experience and review of literature. J Clin Endocrinol Metabol. 2005;90:3077-83.

  8. Terhune KP, Jagasia S, Blevins LS Jr, Phay JE. Diagnostic and therapeutic dilemmas of hipercortisolemia during pregnancy. A case report. Am Surg. 2009;75(3):232-4.

  9. Wallace, C Toth, Lewanczuk RZ, Siminoski K. Pregnancy induced Cushing syndrome in multiples pregnancies. J Clin Endocrinol Metabol. 1996;8:15-21.

  10. Chui MH, Colak N, Ezza S, Kapran Y, Erbil Y, Asa S. Case report: Adrenal LH/HCG recept overexpression and gene amplification causing pregnancy induced Cushing syndrome. Endoc Pathol. 2010;20: 256-61.

  11. Wy LA, Carsol HE, kane P, Li X, Lei ZM, Rao CV. Pregnancy-Associated Cushing, syndrome secondary to a luteinizing hormone/human chorionic gonadotropin receptor-positive adrenal carcinoma. Gynecol Endocrinol. 2002;16(5):413-7.

  12. Nieman LK, Biller B, James W, Findling JW, Newell-Price J, Savage M, et al. The diagnosis of Cushing Syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. May 2008; 93:1526-40.

  13. Sammour R, Saiegh L, Matter I, Gonen R, Shechner C, Cohen M, et al. Adrenalectomy for adrenocortical adenoma causing Cushing's syndrome in pregnancy: a case report and review of literature. Eur J Obstet Gynecol. 2012;165:1-7.

  14. Crane MG, Andes JP, Harris JJ, Slate WG. Primary aldosteronism in Pregnancy. Obstet Gynecol. 1964;23:200-8.

  15. Lebbe M, Arlt W. What is the Best Diagnosis and Therapeutic Managent Strategy for an Addison Patient During Pregnancy? Clin Endocrinol. 2013;78(4):497-502.

  16. Germain A, Kottman C, Valdés G. Hiperaldosteronismo primario y embarazo: lecciones obtenidas de 2 casos clínicos. Rev Méd Chile. 2002;130:1399-405.

  17. Parker C Jr., Cutrer S, Casey ML, McDonald P. Concentrations of deoxycorticosterone, deoxycorticosterone sulfate and progesterone in maternal venous serum and umbilical arterial and venous sera. Am J Obstet Gynecol. 1983;145:427-32.

  18. Ronconi V, Turchi F, Zennaro MC, Boscaro M, Giacchetti G. Progesterone increase counteracts aldosterone actions in a pregnancy woman with primary aldosteronism. Clin Endocrinol (Oxf). 2011;74:278-9.

  19. Zubirán R, Chávez-Manzanera E. Hiperaldosteronismo primario. Un caso de hipertensión e hipocaliemia postparto. Rev Endocrinol y Nutr (Mex). 2012;20(3):116-9.

  20. Okawa T, Asano K, Hashimoto T, Fujimori K, Yanagida K, Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol. 2002;19(1):31-6.

  21. Lampron A, Bourdeau I, Oble S, Godbout A, Schurch W, Arjane P, et al. Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. J Clin Endocrinol Metabol. 2009;94:750-6.

  22. Albiger N, Sartorato P, Mariniello B, Lacobone M, Finco I, Fassina A, et al. A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential rol in regulating aldosterone secretion? Eur J Clin Endocrinol Metab. 2011;164:405-12.

  23. Shigematsu K, Nishida N, Sakai H, Igawa T, Susuki S, Kawuai K, et al. Primary Aldosteronism with Aldosterone-Producing Adenoma Consisting of Pure Zona Glomerulosa-Type Cells in a Pregnant Woman. Endoc Pathol. 2009;20(Issue 1):66-72.

  24. Funder j, Carey R, Fardella C, Gomez-Sanchez C, Mantero F, Stowasser M, et al. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. September 2008;93(9):3266-81.

  25. Peña P, García A, Sánchez P. Hiperaldosteronismo primario. Rev Clin Med Fam Albacete [serie en internet]. oct. 2010 [citado 10 de junio de 2013];3(3). Disponible en: http://dx.doi.org/10.4321/S1699-695X2010000300016.

  26. Fikri O, García R, Cazalla F, Martínez A, González-Spínola J. Diagnóstico de una hipertensión arterial secundaria en una gestante en el primer trimestre como causa de un aborto espontáneo. Nefrología (Madr.) [serie en Internet]. 2011 [citado 10 de junio de 2013];31(2). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_isoref&pid=S0211- 69952011000200023&lng=es&tlng=e

  27. Cabassi A, Rocco R, Berretta R, Regolisti G, Bacchi-Modena A. Eplerenone Use in Primary Aldosteronism During Pregnancy. Hypertension. 2012;59:e18-e19.

  28. Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Phaeochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv. 1999;54(11):728-37.

  29. Vijaya S, Anurag R , Tushar R, Padma S, Nalini S. Pheocromocytoma and pregnancy: a rare but dangerous combination. Endocr Practice. 2010;16(2):300-9.

  30. Oliva R, Angelos P, Kaplan E, Bakris G. Pheocromocytoma in pregnancy: a case series and review. Hypertension. 2010;55:600-6.

  31. Lenders J. Pheocromocytoma and Pregnancy: a deceptive connection. Eur J Endocrinol. 2012;166:143-50.

  32. Akshay S, Desai A, William A, Chutkow W, Edelman E, Dec W Jr. A Crisis in Late Pregnancy. N Engl J Med. 2009;361:2271-7.

  33. Castillo O, Díaz M, Díaz CM, Jara M, Salinas R. Feocromocitoma en el embarazo: reporte de un caso y revisión de la literatura. Rev Chil Urol. 2004;69(2):163-6.

  34. Orduz A, Guevara O, Rojas L, Messa O, Fierro F, Abadia M, et al. Paraganglioma funcional extraadrenal, una causa infrecuente de eclampsia. Rev Colomb CanCeRol. 2011;15(3):47-53.

  35. Bufalino G, Cortés Rl, Sosa H, Yaremenco F. Feocromocitoma asociado con embarazo. Rev Obstet Ginecol Venezuela. sept 2007;67(3):206-11.

  36. Hernández J, Zapata A, Perdomo I, Tamayo LA, Salazar L. Feocromocitoma y metoclopramida. Presentación de 1 caso. Rev Cubana Med. 2001;40(2):148-51.

  37. Lenders J, Pacak K, Huynh T, Sharabi Y, Mannelli M, Bratslavsky G, et al. Low sensitivity of glucagon provocative testing for diagnosis of phaeochromocytoma. J Clin Endocrinol Metab. 2010;95:238-45.

  38. Humphrey R, Gray D, Pautler S, Davies W. Comparación de la adrenalectomía laparoscópica y abierta en la resección del Feocromocitoma. Can J Surg. 2008;51(4):276-80.

  39. Lentschener C, Gaujoux S, Tesniere A, Dousset B. Point of controversy: preoperative care of patients undergoing Pheocromocitoma removal-time for a reappraisal? Eur J Endocrinol. 2011;165:365-73.

  40. Pacak K. Approach to the patient. Preoperative Management of the Pheocromocytoma Patient. The J Clin Endocrinol Metab. 2007;92(11):4069-79.

  41. Bruynzeel H, Feelders R, Groenland T, van den Meiracker A, van Eijck C, Lange J, et al. Risk Factors for Hemodynamic Instability during Surgery for Phaeochromocytoma. J Clin Endocrinol Metab. 2010;95:678-85.

  42. Sanabria CF. Cardiomiopatía severa secundaria a feocromocitoma: utilidad del sulfato de magnesio. Reporte de un caso y revisión de la literatura. RCA. 2013;72:4.




2020     |     www.medigraphic.com